During the past decade, Fredericksburg Oncology, Incorporated conducted 34 clinical trials. In the 10-year time frame, 34 clinical trials started and 146 clinical trials were completed, i.e. on average, 429.4% percent of trials that started reached the finish line to date. In the past 5 years, 10 clinical trials started and 46 clinical trials were completed. i.e. 460% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Fredericksburg Oncology, Incorporated" #1 sponsor was "Alliance for Clinical Trials in Oncology" with 63 trials, followed by "National Cancer Institute (NCI)" with 60 trials sponsored, "SWOG Cancer Research Network" with 28 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 10 trials sponsored and "Eastern Cooperative Oncology Group" with 10 trials sponsored. Other sponsors include 31 different institutions and companies that sponsored additional 26 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Fredericksburg Oncology, Incorporated" #1 collaborator was "National Cancer Institute (NCI)" with 123 trials as a collaborator, "NCIC Clinical Trials Group" with 12 trials as a collaborator, "NRG Oncology" with 12 trials as a collaborator, "Cancer and Leukemia Group B" with 10 trials as a collaborator and "SWOG Cancer Research Network" with 10 trials as a collaborator. Other collaborators include 40 different institutions and companies that were collaborators in the rest 30 trials.

According to Clinical.Site data, the most researched conditions in "Fredericksburg Oncology, Incorporated" are "Breast Cancer" (35 trials), "Lung Cancer" (12 trials), "Unspecified Adult Solid Tumor, Protocol Specific" (12 trials), "Recurrent Squamous Cell Lung Carcinoma" (10 trials) and "Colorectal Cancer" (9 trials). Many other conditions were trialed in "Fredericksburg Oncology, Incorporated" in a lesser frequency.

Most popular intervention types in "Fredericksburg Oncology, Incorporated" are "Drug" (168 trials), "Other" (108 trials), "Biological" (82 trials), "Procedure" (23 trials) and "Radiation" (21 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (58 trials), "placebo" (29 trials), "Quality-of-Life Assessment" (23 trials), "Paclitaxel" (20 trials) and "Bevacizumab" (18 trials). Other intervention names were less common.

The vast majority of trials in "Fredericksburg Oncology, Incorporated" are 164 trials for "All" genders, 35 trials for "Female" genders and 5 trials for "Male" genders.

Currently, there are NaN active trials in "Fredericksburg Oncology, Incorporated". undefined are not yet recruiting, 9 are recruiting, 57 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 117 completed trials in Fredericksburg Oncology, Incorporated, undefined suspended trials, and 17 terminated clinical trials to date.

Out of the total trials that were conducted in Fredericksburg Oncology, Incorporated, 8 "Phase 1" clinical trials were conducted, 82 "Phase 2" clinical trials and 109 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 3 trials that are defined as “Not Applicable".